Anticancer Drugs May Hold Key to Parasite Treatment

LONDON  The genome of the tapeworm has been sequenced, providing researchers with a panoply of genes that may provide new targets for treatment of those parasites. Scientists hope that, by identifying tapeworm genes that are similar to human genes, it may be possible to select candidate drugs that are already approved for use against other conditions, such as cancer.

To continue reading subscribe now to BioWorld Asia (formerly International)